Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)

Authors

Institutions

Publication Details

Journal
American Journal of Health-System Pharmacy
Published
2025-12-20
DOI
https://doi.org/10.1093/ajhp/zxaf338
Citations
1
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
3.13
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)

Brittany L Karas, Mary Golf, Matthew H Rim, Andrew M Levitsky et al.
1 citations
American Journal of Health-System Pharmacy
Pharmaceutical Economics and Policy
3.13
article

Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026)

Brittany L Karas, Mary Golf, Matthew H Rim, Andrew M Levitsky, Maria Cherry, Elizabeth Shepard
article en
1 citations

Abstract

No abstract available for this paper.
American Journal of Health-System PharmacyVol. 83(6)
EP Analytics (United States) (US), Northwestern Medicine (US)
Openalex Percentile: Top 5%
Pharmaceutical Economics and Policy
3.13
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Recent and anticipated novel drug approvals (4Q 2025 through 3Q 2026) — Brittany L Karas, Mary Golf, et al. · American Journal of Health-System Pharmacy (2025) | TGRS Research Map | TGRS